StockData
Zomedica Corp. logo

Zomedica Corp. (ZOMDF) income statement

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica Corp. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
65.4%
Operating margin
-56.3%
Net margin
-51.4%
Return on equity, FY2025
-52.6%

Financial strength

Current ratio
6.43
Debt to equity
–
Debt to assets
–
Cash to current liabilities
79.9%

Valuation

P/E ratio
–
Price to sales
2.10
Price to book
0.72
Dividend yield
–

See a number that looks wrong?